Antitumor immune response during glioma virotherapy
- PMID: 31348516
- PMCID: PMC7594555
- DOI: 10.1093/neuonc/noz114
Antitumor immune response during glioma virotherapy
Comment on
-
Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo.Neuro Oncol. 2019 Sep 6;21(9):1131-1140. doi: 10.1093/neuonc/noz079. Neuro Oncol. 2019. PMID: 31063549 Free PMC article.
References
-
- Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science. 1991;252(5007):854–856. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources